Skip to main content
Premium Trial:

Request an Annual Quote

AIDS Researcher Retracts Findings Made with Ciphergen s ProteinChip/SELDI; Blames Sample Contamination

For an updated version of this story, click here.


NEW YORK, Jan. 23 (GenomeWeb News) - HIV researcher David Ho published a letter in today's issue of Science retracting some of the results of a 2002 paper describing the use of Ciphergen Biosystems' ProteinChip and SELDI-based proteomics platform to identify anti-HIV factors.


Ho said that although the factors identified were real, the sources of the identified proteins were not the CD8 cells, as he reported in the Nov. 1, 2002paper, but were instead contaminating neutrophils that he had used to stimulate the cells before analyzing their proteins. The neutrophils are already known to contain the identified proteins.


"We were pursuing this honestly and came up with new information which clarifies our work and the muddy areas in the field," Ho told the Wall Street Journal in an interview.


It was not immediately clear what, if any, role Ciphergen's technology may have had in the misinterpretation.


The original paper was jointly published by researchers from Ho's AaronDiamondAIDSResearchCenterat RockefellerUniversityin New York, and by researchers from Ciphergen. The retraction was authored only by the Aaron Diamond researchers.


The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.